| Primary |
| Product Used For Unknown Indication |
29.4% |
| Arthralgia |
13.4% |
| Osteoarthritis |
7.0% |
| Back Pain |
6.4% |
| Arthritis |
5.9% |
| Pain |
5.3% |
| Pericardial Effusion |
5.3% |
| Blood Pressure Increased |
3.7% |
| Hypertension |
2.7% |
| Supplementation Therapy |
2.7% |
| Blood Pressure |
2.1% |
| Pain In Extremity |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Ulcer |
2.1% |
| Anxiety |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Bursitis |
1.6% |
| Gout |
1.6% |
| Musculoskeletal Pain |
1.6% |
| Neck Pain |
1.6% |
|
| Cardiac Tamponade |
14.5% |
| Anaphylactic Reaction |
6.5% |
| Incorrect Route Of Drug Administration |
6.5% |
| Joint Swelling |
6.5% |
| Pain |
6.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.8% |
| Off Label Use |
4.8% |
| Rash |
4.8% |
| Renal Failure Acute |
4.8% |
| Tubulointerstitial Nephritis |
4.8% |
| Vomiting |
4.8% |
| Wrong Drug Administered |
4.8% |
| Accidental Exposure |
3.2% |
| Application Site Pain |
3.2% |
| Blister |
3.2% |
| Dizziness |
3.2% |
| Dyspnoea |
3.2% |
| Expired Drug Administered |
3.2% |
| Fatigue |
3.2% |
| Flushing |
3.2% |
|
| Secondary |
| Arthralgia |
16.9% |
| Back Pain |
10.8% |
| Osteoarthritis |
9.6% |
| Sciatica |
9.6% |
| Blood Pressure Increased |
6.0% |
| Pain |
6.0% |
| Anticoagulant Therapy |
4.8% |
| Fracture |
4.8% |
| Ulcer |
4.8% |
| Arthritis |
3.6% |
| Abdominal Pain |
2.4% |
| Blood Cholesterol |
2.4% |
| Blood Pressure |
2.4% |
| Groin Pain |
2.4% |
| Hypertension |
2.4% |
| Musculoskeletal Pain |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Prostatic Disorder |
2.4% |
| Swelling |
2.4% |
| Anxiety |
1.2% |
|
| Off Label Use |
11.1% |
| Chest Pain |
7.4% |
| Completed Suicide |
7.4% |
| Drug Ineffective |
7.4% |
| Erythema |
7.4% |
| International Normalised Ratio Increased |
7.4% |
| Application Site Haematoma |
3.7% |
| Cardio-respiratory Arrest |
3.7% |
| Dizziness |
3.7% |
| Drug Administered At Inappropriate Site |
3.7% |
| Drug Effect Decreased |
3.7% |
| Fatigue |
3.7% |
| Gastrointestinal Disorder |
3.7% |
| Incorrect Route Of Drug Administration |
3.7% |
| Influenza |
3.7% |
| Intentional Drug Misuse |
3.7% |
| Maternal Exposure During Pregnancy |
3.7% |
| Oedema Peripheral |
3.7% |
| Rash |
3.7% |
| Rash Macular |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.0% |
| Rheumatoid Arthritis |
16.3% |
| Drug Use For Unknown Indication |
9.0% |
| Pain |
6.8% |
| Osteoporosis |
4.9% |
| Hypertension |
3.9% |
| Arthritis |
3.2% |
| Epilepsy |
3.2% |
| Vitamin Supplementation |
2.9% |
| Dyspepsia |
2.4% |
| Nausea |
2.2% |
| Supplementation Therapy |
2.2% |
| Anxiety |
1.7% |
| Depression |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Myalgia |
1.7% |
| Psoriasis |
1.7% |
| Back Pain |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Neuralgia |
1.5% |
|
| Pyrexia |
9.5% |
| Lymphoma |
7.1% |
| Pain |
7.1% |
| Pain In Extremity |
7.1% |
| Pulmonary Embolism |
7.1% |
| Retinal Detachment |
7.1% |
| Death |
4.8% |
| Drug Ineffective |
4.8% |
| Epilepsy |
4.8% |
| International Normalised Ratio Decreased |
4.8% |
| International Normalised Ratio Increased |
4.8% |
| Large Intestinal Haemorrhage |
4.8% |
| Non-small Cell Lung Cancer Metastatic |
4.8% |
| Painful Respiration |
4.8% |
| Red Blood Cell Count Decreased |
4.8% |
| Angioedema |
2.4% |
| Bruxism |
2.4% |
| Cerebellar Syndrome |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Dermatitis Bullous |
2.4% |
|
